CPH Insider Trading

Insider Ownership Percentage: 42.00%
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$47,215.00

Cipher Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Cipher Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cipher Pharmaceuticals Share Price & Price History

Current Price: C$12.00
Price Change: Price Increase of +0.53 (4.62%)
As of 04/24/2025 04:03 PM ET

This chart shows the closing price history over time for CPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cipher Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/24/2025Harold Morton WolkinDirectorSell3,500C$13.49C$47,215.00
12/9/2022Christian GodinDirectorSell4,000C$3.90C$15,600.0099,210
12/7/2022Christian GodinDirectorSell5,000C$3.70C$18,500.00106,210
See Full Table

SEC Filings (Institutional Ownership Changes) for Cipher Pharmaceuticals (TSE:CPH)

1.38% of Cipher Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Cipher Pharmaceuticals logo
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.
Read More on Cipher Pharmaceuticals

Today's Range

Now: C$12.00
Low: C$11.66
High: C$12.10

50 Day Range

MA: C$12.06
Low: C$10.92
High: C$13.49

52 Week Range

Now: C$12.00
Low: C$8.01
High: C$19.69

Volume

15,297 shs

Average Volume

34,691 shs

Market Capitalization

C$215.44 million

P/E Ratio

13.25

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Cipher Pharmaceuticals?

Cipher Pharmaceuticals' top insider shareholders include:
  1. Harold Morton Wolkin (Director)
Learn More about top insider investors at Cipher Pharmaceuticals.